[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Orphan Diseases Market Report (Status and Outlook)

August 2018 | 131 pages | ID: 2515BCA9DF1EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Orphan Diseases market for 2018-2023.

An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Over the next five years, LPI(LP Information) projects that Orphan Diseases will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Orphan Diseases market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Autoimmune Disorders
  • Genetic Disorders
  • Cancer
  • Growth Disorder
  • Cardiovascular Diseases
  • Neurological Disorders
  • Respiratory Disorders
  • Digestive Disorders
  • Eye Disorders
Segmentation by application:
  • Hospitals And Clinics
  • Research Laboratories
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Bristol-Myers Squibb
  • Novartis
  • Celgene
  • Roche
  • Pfizer
  • Alexion
  • Sanofi
  • Vertex Pharmaceuticals
  • GlaxoSmithKline
  • Merck
  • Abbvie
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Orphan Diseases market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Orphan Diseases market by identifying its various subsegments.
  • Focuses on the key global Orphan Diseases players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Orphan Diseases with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Orphan Diseases submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Orphan Diseases Market Size 2013-2023
  2.1.2 Orphan Diseases Market Size CAGR by Region
2.2 Orphan Diseases Segment by Type
  2.2.1 Autoimmune Disorders
  2.2.2 Genetic Disorders
  2.2.3 Blood Disorders
  2.2.4 Cancer
  2.2.5 Growth Disorder
  2.2.6 Cardiovascular Diseases
  2.2.7 Neurological Disorders
  2.2.8 Respiratory Disorders
  2.2.9 Digestive Disorders
  2.2.10 Eye Disorders
2.3 Orphan Diseases Market Size by Type
  2.3.1 Global Orphan Diseases Market Size Market Share by Type (2013-2018)
  2.3.2 Global Orphan Diseases Market Size Growth Rate by Type (2013-2018)
2.4 Orphan Diseases Segment by Application
  2.4.1 Hospitals And Clinics
  2.4.2 Research Laboratories
2.5 Orphan Diseases Market Size by Application
  2.5.1 Global Orphan Diseases Market Size Market Share by Application (2013-2018)
  2.5.2 Global Orphan Diseases Market Size Growth Rate by Application (2013-2018)

3 GLOBAL ORPHAN DISEASES BY PLAYERS

3.1 Global Orphan Diseases Market Size Market Share by Players
  3.1.1 Global Orphan Diseases Market Size by Players (2016-2018)
  3.1.2 Global Orphan Diseases Market Size Market Share by Players (2016-2018)
3.2 Global Orphan Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORPHAN DISEASES BY REGIONS

4.1 Orphan Diseases Market Size by Regions
4.2 Americas Orphan Diseases Market Size Growth
4.3 APAC Orphan Diseases Market Size Growth
4.4 Europe Orphan Diseases Market Size Growth
4.5 Middle East & Africa Orphan Diseases Market Size Growth

5 AMERICAS

5.1 Americas Orphan Diseases Market Size by Countries
5.2 Americas Orphan Diseases Market Size by Type
5.3 Americas Orphan Diseases Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Orphan Diseases Market Size by Countries
6.2 APAC Orphan Diseases Market Size by Type
6.3 APAC Orphan Diseases Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Orphan Diseases by Countries
7.2 Europe Orphan Diseases Market Size by Type
7.3 Europe Orphan Diseases Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Orphan Diseases by Countries
8.2 Middle East & Africa Orphan Diseases Market Size by Type
8.3 Middle East & Africa Orphan Diseases Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL ORPHAN DISEASES MARKET FORECAST

10.1 Global Orphan Diseases Market Size Forecast (2018-2023)
10.2 Global Orphan Diseases Forecast by Regions
  10.2.1 Global Orphan Diseases Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Orphan Diseases Forecast by Type
10.8 Global Orphan Diseases Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb
  11.1.1 Company Details
  11.1.2 Orphan Diseases Product Offered
  11.1.3 Bristol-Myers Squibb Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Bristol-Myers Squibb News
11.2 Novartis
  11.2.1 Company Details
  11.2.2 Orphan Diseases Product Offered
  11.2.3 Novartis Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Novartis News
11.3 Celgene
  11.3.1 Company Details
  11.3.2 Orphan Diseases Product Offered
  11.3.3 Celgene Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Celgene News
11.4 Roche
  11.4.1 Company Details
  11.4.2 Orphan Diseases Product Offered
  11.4.3 Roche Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Roche News
11.5 Pfizer
  11.5.1 Company Details
  11.5.2 Orphan Diseases Product Offered
  11.5.3 Pfizer Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Pfizer News
11.6 Alexion
  11.6.1 Company Details
  11.6.2 Orphan Diseases Product Offered
  11.6.3 Alexion Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Alexion News
11.7 Sanofi
  11.7.1 Company Details
  11.7.2 Orphan Diseases Product Offered
  11.7.3 Sanofi Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Sanofi News
11.8 Vertex Pharmaceuticals
  11.8.1 Company Details
  11.8.2 Orphan Diseases Product Offered
  11.8.3 Vertex Pharmaceuticals Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Vertex Pharmaceuticals News
11.9 GlaxoSmithKline
  11.9.1 Company Details
  11.9.2 Orphan Diseases Product Offered
  11.9.3 GlaxoSmithKline Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 GlaxoSmithKline News
11.10 Merck
  11.10.1 Company Details
  11.10.2 Orphan Diseases Product Offered
  11.10.3 Merck Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Merck News
11.11 Abbvie

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Orphan Diseases
Figure Orphan Diseases Report Years Considered
Figure Market Research Methodology
Figure Global Orphan Diseases Market Size Growth Rate 2013-2023 (


More Publications